Cargando…

Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study

BACKGROUND: Classification of patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) into histological classes is useful for predicting a patient's risk of progression to end-stage renal disease (ESRD). However, even in the worst prognostic group, the 5-year...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjørneklett, Rune, Solbakken, Vilde, Bostad, Leif, Fismen, Anne-Siri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008801/
https://www.ncbi.nlm.nih.gov/pubmed/29973979
http://dx.doi.org/10.1155/2018/5653612
_version_ 1783333252408279040
author Bjørneklett, Rune
Solbakken, Vilde
Bostad, Leif
Fismen, Anne-Siri
author_facet Bjørneklett, Rune
Solbakken, Vilde
Bostad, Leif
Fismen, Anne-Siri
author_sort Bjørneklett, Rune
collection PubMed
description BACKGROUND: Classification of patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) into histological classes is useful for predicting a patient's risk of progression to end-stage renal disease (ESRD). However, even in the worst prognostic group, the 5-year end-stage renal disease-free survival rate is as high as 50%. OBJECTIVES: To investigate those prognostic factors indicative of progression to ESRD in patients with ANCA-GN and sclerosing histology. METHODS: Patients from the Norwegian Kidney Biopsy Registry between 1991 and 2012 who had biopsy verified pauci-immune glomerulonephritis, positive ANCA serology, and sclerosing histology were included. Cases with ESRD during follow-up were identified via linkage with the Norwegian Renal Registry. Potential prognostic factors with relevant cut-offs were compared in patients with and without progression to ESRD during follow-up. RESULTS: Of 23 included patients, 10 progressed to ESRD. ESRD patients had a lower initial estimated glomerular filtration rate (eGFR; 21 versus 52 ml/min/1.73 m(2)) and a lower percentage of normal glomeruli (4% versus 15%). Five-year risks of ESRD with eGFR >15 versus ≤15 ml/min/1.73 m(2) were 77% and 15%, with percentage normal glomeruli >10% versus ≤10%, 83% and 39%. CONCLUSIONS: eGFR and percentage of normal glomeruli are strong risk factors for ESRD in ANCA-GN with sclerosing histology.
format Online
Article
Text
id pubmed-6008801
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-60088012018-07-04 Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study Bjørneklett, Rune Solbakken, Vilde Bostad, Leif Fismen, Anne-Siri Patholog Res Int Research Article BACKGROUND: Classification of patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) into histological classes is useful for predicting a patient's risk of progression to end-stage renal disease (ESRD). However, even in the worst prognostic group, the 5-year end-stage renal disease-free survival rate is as high as 50%. OBJECTIVES: To investigate those prognostic factors indicative of progression to ESRD in patients with ANCA-GN and sclerosing histology. METHODS: Patients from the Norwegian Kidney Biopsy Registry between 1991 and 2012 who had biopsy verified pauci-immune glomerulonephritis, positive ANCA serology, and sclerosing histology were included. Cases with ESRD during follow-up were identified via linkage with the Norwegian Renal Registry. Potential prognostic factors with relevant cut-offs were compared in patients with and without progression to ESRD during follow-up. RESULTS: Of 23 included patients, 10 progressed to ESRD. ESRD patients had a lower initial estimated glomerular filtration rate (eGFR; 21 versus 52 ml/min/1.73 m(2)) and a lower percentage of normal glomeruli (4% versus 15%). Five-year risks of ESRD with eGFR >15 versus ≤15 ml/min/1.73 m(2) were 77% and 15%, with percentage normal glomeruli >10% versus ≤10%, 83% and 39%. CONCLUSIONS: eGFR and percentage of normal glomeruli are strong risk factors for ESRD in ANCA-GN with sclerosing histology. Hindawi 2018-06-03 /pmc/articles/PMC6008801/ /pubmed/29973979 http://dx.doi.org/10.1155/2018/5653612 Text en Copyright © 2018 Rune Bjørneklett et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Bjørneklett, Rune
Solbakken, Vilde
Bostad, Leif
Fismen, Anne-Siri
Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
title Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
title_full Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
title_fullStr Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
title_full_unstemmed Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
title_short Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study
title_sort prognostic factors in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with severe glomerular sclerosis: a national registry-based cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008801/
https://www.ncbi.nlm.nih.gov/pubmed/29973979
http://dx.doi.org/10.1155/2018/5653612
work_keys_str_mv AT bjørneklettrune prognosticfactorsinantineutrophilcytoplasmicantibodyassociatedglomerulonephritiswithsevereglomerularsclerosisanationalregistrybasedcohortstudy
AT solbakkenvilde prognosticfactorsinantineutrophilcytoplasmicantibodyassociatedglomerulonephritiswithsevereglomerularsclerosisanationalregistrybasedcohortstudy
AT bostadleif prognosticfactorsinantineutrophilcytoplasmicantibodyassociatedglomerulonephritiswithsevereglomerularsclerosisanationalregistrybasedcohortstudy
AT fismenannesiri prognosticfactorsinantineutrophilcytoplasmicantibodyassociatedglomerulonephritiswithsevereglomerularsclerosisanationalregistrybasedcohortstudy